American Century Companies Inc Arcturus Therapeutics Holdings Inc. Transaction History
American Century Companies Inc
- $168 Billion
- Q4 2024
A detailed history of American Century Companies Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, American Century Companies Inc holds 47,018 shares of ARCT stock, worth $835,509. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,018
Previous 42,471
10.71%
Holding current value
$835,509
Previous $985,000
19.09%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ARCT
# of Institutions
168Shares Held
26MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$83.4 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$47.1 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$36.7 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$36.7 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$34.4 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $472M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...